This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Brian Dangel: Innovator in Antibacterial Research
Introduction
Brian Dangel is a notable inventor based in Somerville, MA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of antibacterial agents. His work focuses on innovative compounds that have the potential to combat bacterial infections effectively.
Latest Patents
Brian Dangel holds a patent for "Antibacterial piperdine derivatives." This patent describes compounds of formula (I) and their pharmaceutically acceptable salts. The patent also outlines processes for their preparation, pharmaceutical compositions containing them, their use as medicaments, and their application in the treatment of bacterial infections. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Brian Dangel is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His role involves research and development in the field of antibacterial medications, where he applies his expertise to create innovative solutions for healthcare challenges.
Collaborations
Throughout his career, Brian has collaborated with esteemed colleagues, including Gregory Steven Basarab and Paul Robert Fleming. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Brian Dangel's contributions to antibacterial research exemplify the importance of innovation in medicine. His work not only addresses critical health issues but also paves the way for future advancements in the field.